Luong Tsai

机构：Gilead Sciences (United States)

发表论文 19 篇 · 总被引 1730 次 · h-index 12

代表论文

• Clinical targeting of HIV capsid protein with a long-acting small molecule (2020 · Nature · 被引 436)
• Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile (2016 · Antimicrobial Agents and Chemotherapy · 被引 288)
• Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer (2010 · ACS Medicinal Chemistry Letters · 被引 200)
• Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid (2014 · eLife · 被引 166)
• Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells (2013 · PLoS ONE · 被引 128)
• EFG1 Null Mutants of Candida albicans Switch but Cannot Express the Complete Phenotype of White-Phase Budding Cells (2000 · Journal of Bacteriology · 被引 122)